Literature DB >> 20657612

Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.

Nadzeya Kuzniatsova, Eduard Shantsila, Gregory Y H Lip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20657612     DOI： 10.1038/nrcardio.2010.103

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.

Authors:  Marcello Disertori; Federico Lombardi; Simona Barlera; Roberto Latini; Aldo P Maggioni; Prisca Zeni; Giuseppe Di Pasquale; Franco Cosmi; Maria Grazia Franzosi
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

2.  Absence of acute effects of angiotensin II on atrial electrophysiology in humans.

Authors:  Peter M Kistler; Neil C Davidson; Prashanthan Sanders; Simon P Fynn; Irene H Stevenson; Steven J Spence; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

3.  In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.

Authors:  Kristian Wachtell; Eva Gerdts; Gerard P Aurigemma; Kurt Boman; Björn Dahlöf; Markku S Nieminen; Michael Hecht Olsen; Peter M Okin; Vittorio Palmieri; Jens E Rokkedal; Richard B Devereux
Journal:  Blood Press       Date:  2010-06       Impact factor: 2.835

Review 4.  Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.

Authors:  Markus P Schneider; Tsushung A Hua; Michael Böhm; Kristian Wachtell; Sverre E Kjeldsen; Roland E Schmieder
Journal:  J Am Coll Cardiol       Date:  2010-05-25       Impact factor: 24.094

5.  Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Authors:  Jeff S Healey; Adrian Baranchuk; Eugene Crystal; Carlos A Morillo; Michael Garfinkle; Salim Yusuf; Stuart J Connolly
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

6.  Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Authors:  Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Richard B Devereux
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

7.  The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution.

Authors:  O D Pedersen; H Bagger; L Køber; C Torp-Pedersen
Journal:  Eur Heart J       Date:  1999-05       Impact factor: 29.983

Review 8.  Lone atrial fibrillation: what do we know?

Authors:  Dariusz Kozlowski; Szymon Budrejko; Gregory Y H Lip; Jacek Rysz; Dimitri P Mikhailidis; Grzegorz Raczak; Maciej Banach
Journal:  Heart       Date:  2009-08-26       Impact factor: 5.994

9.  Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.

Authors:  Emmanuelle Vermes; Jean-Claude Tardif; Martial G Bourassa; Normand Racine; Sylvie Levesque; Michel White; Peter G Guerra; Anique Ducharme
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

10.  Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.

Authors:  Laurent Ferron; Véronique Capuano; Yann Ruchon; Edith Deroubaix; Alain Coulombe; Jean-François Renaud
Journal:  Circ Res       Date:  2003-11-13       Impact factor: 17.367
  10 in total
  2 in total

1.  Renin-angiotensin blockade in atrial fibrillation: where are we now?

Authors:  F Shahid; G Y H Lip; E Shantsila
Journal:  J Hum Hypertens       Date:  2017-07       Impact factor: 3.012

2.  Causal effects of atrial fibrillation on brain white and gray matter volume: a Mendelian randomization study.

Authors:  Sehoon Park; Soojin Lee; Yaerim Kim; Semin Cho; Kwangsoo Kim; Yong Chul Kim; Seung Seok Han; Hajeong Lee; Jung Pyo Lee; Soryoung Lee; Eue-Keun Choi; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  BMC Med       Date:  2021-11-24       Impact factor: 8.775
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.